BioCryst’s HAE drug BCX7353 gets FDA fast track designation

Image: FDA grants orphan drug designation to Onspira Therapeutics’ Investigational Interleukin-1 Receptor antagonist. Photo: courtesy of The U.S. Food and Drug Administration/Wikipedia.org.